C-reactive protein to albumin ratio predict responses to programmed cell death-1 inhibitors in hepatocellular carcinoma patients

Figure 2 Nomogram models of overall survival and progression-free survival in hepatocellular carcinoma patients. A: Nomogram models of overall survival at 12, 18 and 24 mo in hepatocellular carcinoma (HCC) patients; B: Nomogram model of progression-free survival at 9, 12 and 15 mo in HCC patients. C-reactive protein to albumin ratio (CAR) = 0 means CAR ≤ 1.20, CAR = 1 means CAR > 1.20; tumor number = 0 means single tumor, tumor number = 1 means multiple tumors. CAR: C-reactive protein to albumin ratio; NLR: Neutrophil-to-lymphocyte ratio; ECOG PS: Eastern Cooperative Oncology Group performance status.